Sun Pharmaceutical Industries Ltd vs Vivimed Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Sun Pharmaceutical Industries Ltd is ₹ 1808 as of 30 Apr 15:30 . The P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 49.4 on March 2021 to 38.1 on March 2025 . This represents a CAGR of -5.06% over 5 yearsThe P/E Ratio of Vivimed Labs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 143384 crore on March 2021 to ₹ 416392 crore on March 2025 . This represents a CAGR of 23.77% over 5 yearsThe Market Cap of Vivimed Labs Ltd changed from ₹ 131.42 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Sun Pharmaceutical Industries Ltd for the Dec '25 is ₹ 16099 crore as compare to the Sep '25 revenue of ₹ 14948 crore. This represent the growth of 7.7% The revenue of Vivimed Labs Ltd for the Dec '25 is ₹ 15.99 crore as compare to the Sep '25 revenue of ₹ 20.82 crore. This represent the decline of -23.2% The ebitda of Sun Pharmaceutical Industries Ltd for the Dec '25 is ₹ 5037 crore as compare to the Sep '25 ebitda of ₹ 4996 crore. This represent the growth of 0.82% The ebitda of Vivimed Labs Ltd for the Dec '25 is ₹ -10.92 crore as compare to the Sep '25 ebitda of ₹ -0.74 crore. This represent the growth of 1375% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2871 crore to ₹ 3401 crore over 7 quarters. This represents a CAGR of 10.16% The net profit of Vivimed Labs Ltd changed from ₹ -15.25 crore to ₹ -16.55 crore over 7 quarters. This represents a CAGR of 4.79% The Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 213.61 % on March 2021 to 89.64 % on March 2025 . This represents a CAGR of -15.94% over 5 yearsThe Dividend Payout of Vivimed Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

About Vivimed Labs Ltd

Vivimed Labs Limited was originally incorporated on September 22, 1988 as a private limited company in the name of Emgi Pharmaceuticals & Chemicals Pvt Ltd. On April 21, 1994, the company got converted into a public limited company and the name was changed to Emgi Pharmaceuticals & Chemicals Ltd and thereafter, the Company name was finally changed to Vivimed Labs Limited on April 22, 1997. The Company is engaged in manufacturing of Specialty Chemicals (mainly used in Personal Care and Cosmetic Industry), Pharmaceuticals, API's and Formulations.
The company has strong presence in the areas of Health & Personal Care, Contract Research and Manufacturing.
The company has four subsidiary companies, namely Creative Health Care Pvt Ltd, Vivimed Holdings Ltd (Hong Kong), Vivimed Labs Europe Ltd (UK) and Vivimed Labs USA Inc.

FAQs for the comparison of Sun Pharmaceutical Industries Ltd and Vivimed Labs Ltd

Which company has a larger market capitalization, Sun Pharmaceutical Industries Ltd or Vivimed Labs Ltd?

Market cap of Sun Pharmaceutical Industries Ltd is 433,847 Cr while Market cap of Vivimed Labs Ltd is 56 Cr

What are the key factors driving the stock performance of Sun Pharmaceutical Industries Ltd and Vivimed Labs Ltd?

The stock performance of Sun Pharmaceutical Industries Ltd and Vivimed Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharmaceutical Industries Ltd and Vivimed Labs Ltd?

As of May 3, 2026, the Sun Pharmaceutical Industries Ltd stock price is INR ₹1808.2. On the other hand, Vivimed Labs Ltd stock price is INR ₹6.77.

How do dividend payouts of Sun Pharmaceutical Industries Ltd and Vivimed Labs Ltd compare?

To compare the dividend payouts of Sun Pharmaceutical Industries Ltd and Vivimed Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.